If you had a little more energy, what would you do with it? If your hands felt stronger or getting out of bed came easier, what would that feel like? If you felt more motivated to do the things you love, how would your life change?
For those of us living with myotonic dystrophy type 1 (DM1), a disease that can slowly take away so much, questions like these are rarely something we get to consider. But what if we could? What would that life look like? A place where you could live out the dreams you’ve always had. A life that isn’t defined by a diagnosis or challenges that sometimes feel impossible to overcome.
My diagnosis came five years ago, and only two years after my first symptom. I was a morning news reporter, anchor and meteorologist in the Midwest, and one random morning while live on air, I suddenly couldn’t pronounce the words that were rolling across the teleprompter in front of me. I didn’t think much of it at the time and felt grateful nobody seemed to notice.
The following year, this began to happen with a bit more regularity, but always in a stressful moment. I have a family full of healthcare professionals who were puzzled, but we bounced around the possibility that it was stress-induced or an electrolyte deficiency or something else even more benign. I continued to scour the internet high and low, as any journalist would, but to no avail. This was a terrifying time for me, imagining the worst and getting on air daily, never knowing when or if I’d struggle to get the words out.
Many months down the road, a similar thing started happening in my hands, at first while opening a sealed jar and later while cutting bread. At this point, I knew something wasn’t right. I walked into my first neurology appointment with a list of the strange symptoms I had been experiencing. I showed the doctor how my hands would freeze while pulling off my boots. I explained that a similar thing would happen to my mouth after biting into a sandwich. I also mentioned how much worse my pronunciation became in the cold. He told me I was describing many hallmark symptoms without realizing it, and I walked out with “Myotonic Dystrophy” circled across the top of my After-Visit Summary. There weren’t any treatments or cures, and a few months later, genetic testing confirmed what he had suspected.
It took many months and several cold calls, but eventually I found a neurologist who specialized in this disease. He explained that while we couldn’t treat the disease, we could manage some of the symptoms with medication, physical therapy and assistive devices. I specifically remember him saying with confidence, “There will be treatments in your lifetime.” But how far off would that be? I wasn’t going to place my hope in something that could be decades away. Fast forward five years, and the lens through which I see this disease now looks very different than it did in those first few months.
September 15th, International Myotonic Dystrophy Awareness Day, is an opportunity to bring attention to a disease many people have never heard of. But this year, for me, it’s also an opportunity to recognize just how much has changed, not only in the five years since my diagnosis, but in research that could shape what comes next.
This year was the first time I felt compelled to attend a conference, and I stepped into the DM community at a moment when there was more reason than ever to feel hopeful about what could come next. I flew down to Palo Alto in hopes of connecting with providers, patients and advocates, all in one place at the Myotonic Dystrophy Foundation (MDF) regional conference. I saw this as a place to be seen and understood by others in a way I had never experienced before, and a place to get answers from experts to the disease-related questions I frequently ponder: Could pregnancy make the symptoms worse?
Am I exercising too much or too little? What can I do to improve my outcome… or can I do anything to improve my outcome? Should I allow myself to sleep as much as my body begs to? I found answers to those questions, but I left at the end of the day with something so much greater. Hearing firsthand about the progress being made in research and the treatments that could be on the horizon, shared by the very people working to make them a reality, gave me a renewed sense of possibility.
This planted a seed of hope for me and hundreds of others who are impacted by this disease. But hope like that raises an immediate question: hope for what exactly? Because with any seed, what we each hope to see grow from that seed is a little different from person to person. In the clinical world, those potential individualized benefits are called functional improvements.
The variation in what we hope for is reflected in the disease itself. DM1 can present very differently from one person to the next, even within the same family.
For researchers and biotech companies working to develop treatments and therapies, this variability creates another layer of complexity. What improvements matter most to patients? They’re working to figure that out.
Dyne Therapeutics, a biotech company developing treatments for DM1, explored this question directly with the community through an activity at multiple MDF Regional Conferences, including the one I attended earlier this year. Using post-it notes, attendees were asked: “What does functional improvement mean to you?”
As members of the DM community vulnerably scribbled out their own personal answers, both the variability of the disease and its impact were glaring.
So, while functional improvement may sound unclear at first, it becomes very specific when you ask a patient. It’s discussed clinically, but patients experience it personally, every day. A common theme is echoed in every answer: more energy. More ease. More life. I see and feel these moments myself.
It’s the accumulation of many small things that adds up to a different life for all of us. Small improvements could create major quality-of-life changes. It’s the difference between napping in the afternoon or going for a walk… or simply having enough energy to want to. These are the moments that give us back more life.
We don’t yet know if research will become reality, or what shape “more” will finally take… strength, clearer speech, dancing, working, seeing better, or something else entirely. But for the first time since my diagnosis five years ago, I’m allowing myself to imagine what “more” could mean for me, and I’m staying hopeful for what’s ahead.
On International Myotonic Dystrophy Awareness Day, that feels like something worth celebrating: the progress already made, the work still underway and the possibility of more.
Published Septermber 10, 2026
Disclosure: Emily Blume was compensated by Dyne Therapeutics for her contributions to this article.